Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

FRC 8653

Known as: FRC-8653 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Cilnidipine (FRC-8653), a new dihydropyridine calcium antagonist, was given to 14 hospitalized patients with essential… 
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Highly Cited
1997
Highly Cited
1997
1 The inhibitory effects of cilnidipine (FRC‐8653) and various organic Ca2+ channel blockers on high voltage‐activated Ba2… 
1995
1995
Effect of cilnidipine, a new calcium antagonist, on autoregulation of cerebral blood flow was studied in spontaneously… 
1992
1992
Antihypertensive effects of FRC-8653, a new 1,4-dihydropyridine derivative, and its combined effects with an angiotensin… 
1992
1992
The characteristics of calcium antagonism and vascular effect of 2-methoxyethyl(E)-3-phenyl-2-propen-1-yl(+/-)-1,4-dihydro-2,6… 
1992
1992
Effects of FRC 8653, a new dihydropyridine derivative, on regional blood flow, cardiac function and myocardial oxygen consumption… 
1992
1992
A highly sensitive thermospray liquid chromatographic-mass spectrometric method has been developed for the simultaneous… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1991
1991
We examined the effects of FRC-8653, a novel dihydropyridine calcium antagonist, on the contraction of an arterial preparation… 
1991
1991
In ring preparations of the rabbit mesenteric artery, the Ca-contraction, but not the noradrenaline (NA)-contraction, was…